{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:03:05Z","timestamp":1793329385298,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00467-016-3559-2","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T19:54:52Z","timestamp":1483732492000},"page":"25-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management"],"prefix":"10.1007","volume":"33","author":[{"given":"Lucy A","family":"Plumb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2390","authenticated-orcid":false,"given":"Louise","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"issue":"5","key":"3559_CR1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","volume":"57","author":"JD Akikusa","year":"2007","unstructured":"Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener\u2019s granulomatosis. Arthritis Rheum 57(5):837\u2013844","journal-title":"Arthritis Rheum"},{"key":"3559_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00467-002-0914-2","volume":"17","author":"VM Belostostky","year":"2002","unstructured":"Belostostky VM, Shah V, Dillon MJ (2002) Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17:754\u2013761","journal-title":"Pediatr Nephrol"},{"key":"3559_CR3","doi-asserted-by":"crossref","unstructured":"Arulkumaran N, Jawad S, Smith SW, Harper L, Brogan P, Pusey CD, Salama AD (2011) Long- term outcome of paediatric patients with ANCA vasculitis. Pediatr Rheumatol Online J 9:12. http:\/\/www.ped-rheum.com\/content\/9\/1\/12","DOI":"10.1186\/1546-0096-9-12"},{"issue":"7","key":"3559_CR4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65(7):936\u2013941","journal-title":"Ann Rheum Dis."},{"key":"3559_CR5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"3559_CR6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3559_CR7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3899\/jrheum.111352","volume":"39","author":"AG Uribe","year":"2012","unstructured":"Uribe AG, Huber AM, Kim S, O\u2019Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA, ARegistry for Children with Vasculitis e-entry (ARChiVe) Network (2012) Increased sensitivity of the European Medicines Agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol 39(8):1687\u20131697","journal-title":"J Rheumatol"},{"issue":"1","key":"3559_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"key":"3559_CR9","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2009.119032","volume":"69","author":"N Basu","year":"2010","unstructured":"Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DG, Segelmark M, Specks U, Sunderk\u00f6etter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 69:1744\u20131750","journal-title":"Ann Rheum Dis"},{"key":"3559_CR10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","volume":"360","author":"JMM Gardner-medwin","year":"2002","unstructured":"Gardner-medwin JMM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197\u20131202","journal-title":"Lancet"},{"issue":"3","key":"3559_CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004670050043","volume":"14","author":"BG Stegmayr","year":"2000","unstructured":"Stegmayr BG, Gothefors L, Malmer B, M\u00fcller Wiefel DE, Nilsson K, Sundelin B (2000) Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol 14(3):208\u2013213","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3559_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3899\/jrheum.090688","volume":"37","author":"S Grisaru","year":"2013","unstructured":"Grisaru S, Yuen GWH, Miettunen PM, Lorraine A (2013) Incidence of Wegener\u2019s granulomatosis in children. J Rheumatol 37(2):440\u2013442","journal-title":"J Rheumatol"},{"key":"3559_CR13","unstructured":"Mahr AD, Neogi T, Merkel PA (2006) Epidemiology of Wegener\u2019s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol Suppl 41:S82\u201391"},{"key":"3559_CR14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00467-005-2063-x","volume":"21","author":"A Peco-Antic","year":"2006","unstructured":"Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G, Kostic M, Markovic-Lipkovski J, Nikolic M, Spasojevic B (2006) Childhood microscopic polyangiitis associated with MPO-ANCA. Pediatr Nephrol 21:46\u201353","journal-title":"Pediatr Nephrol"},{"key":"3559_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.85.5.427","volume":"85","author":"A Bakkaloglu","year":"2001","unstructured":"Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasap\u00e7opur O, Tinaztepe K (2001) The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch Dis Child 85:427\u2013430","journal-title":"Arch Dis Child"},{"issue":"3","key":"3559_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0031-1279824","volume":"32","author":"A Gibelin","year":"2011","unstructured":"Gibelin A, Maldini C, Mahr A (2011) Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and Goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32(3):264\u2013273","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"3559_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture\u2013recapture estimate. Arthritis Rheum 51(1):92\u201399","journal-title":"Arthritis Rheum"},{"key":"3559_CR18","doi-asserted-by":"crossref","unstructured":"Kallenberg CGM (2011) Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 70 [Suppl 1]:i59\u201363","DOI":"10.1136\/ard.2010.138024"},{"issue":"12","key":"3559_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","volume":"2","author":"CGM Kallenberg","year":"2006","unstructured":"Kallenberg CGM, Heeringa P, Stegeman CA (2006) Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2(12):661\u2013670","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"11","key":"3559_CR20","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.24876","volume":"60","author":"DA Cabral","year":"2009","unstructured":"Cabral DA, Uribe AG, Benseler S, O\u2019Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A, ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators (2009) Classification, presentation, and initial treatment of Wegener\u2019s granulomatosis in childhood. Arthritis Rheum 60(11):3413\u20133424","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3559_CR21","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87(11):4115\u20134119","journal-title":"Proc Natl Acad Sci USA"},{"key":"3559_CR22","doi-asserted-by":"crossref","unstructured":"Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG, for the Dutch Co-trimoxazole Wegener Study Group (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. N Engl J Med 335(1):16\u201320.","DOI":"10.1056\/NEJM199607043350103"},{"issue":"Suppl 4","key":"3559_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/2047-783X-14-S4-265","volume":"14","author":"K Zycinska","year":"2009","unstructured":"Zycinska K, Wardyn KA, Zielonka TM, Krupa R, Lukas W (2009) Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement. Eur J Med Res 14[Suppl 4]:265\u2013267","journal-title":"Eur J Med Res"},{"issue":"3","key":"3559_CR24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hru\u0161kov\u00e1 Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesa\u0159 V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214\u2013223","journal-title":"N Engl J Med"},{"key":"3559_CR25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","volume":"65","author":"M Haas","year":"2004","unstructured":"Haas M, Eustace JA (2004) Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases. Kidney Int 65:2145\u20132152","journal-title":"Kidney Int"},{"key":"3559_CR26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, No\u00ebl LH, Waldherr R, Ayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (2002) Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int 61:80\u201389","journal-title":"Kidney Int"},{"issue":"6","key":"3559_CR27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005792-197311000-00002","volume":"52","author":"AS Fauci","year":"1973","unstructured":"Fauci AS, Wolff SM (1973) Wegener\u2019s granulomatosis: studies in eighteen patients and a review of the literature. Medicine 52(6):535\u2013561","journal-title":"Medicine"},{"issue":"8","key":"3559_CR28","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.2005080870","volume":"17","author":"RAF Wijngaarden de Lind van","year":"2006","unstructured":"de Lind van Wijngaarden RAF (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17(8):2264\u20132274","journal-title":"J Am Soc Nephrol"},{"key":"3559_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","volume":"7","author":"H Nachman","year":"1996","unstructured":"Nachman H, Hogan SL, Jennette JC, Falk RJ (1996) Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:33\u201339","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3559_CR30","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1523-1755.1999.00758.x","volume":"56","author":"IM Bajema","year":"1999","unstructured":"Bajema IM, Christiaan Hagen E, Hermans J, No\u00ebl LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56(5):1751\u20131758","journal-title":"Kidney Int"},{"key":"3559_CR31","doi-asserted-by":"crossref","unstructured":"Joh K, Muso E, Shigematsu H, Nose M, Nagata M, Arimura Y, Yumura W, Wada T, Nitta K, Makino H, Taguma Y, Kaneoka H, Suzuki Y, Kobayashi M, Koyama A, Usui J, Hashimoto H, Ozaki S, Tomino Y, Yamagata K (2008) Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol 12:277\u2013291","DOI":"10.1007\/s10157-008-0052-7"},{"key":"3559_CR32","unstructured":"Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O\u2019Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative (2016) Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener\u2019s): an ARChiVe cohort study. Arthritis Rheumatol 68(10):2514\u20132526"},{"issue":"1","key":"3559_CR33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(05)83482-1","volume":"122","author":"M Rottem","year":"1993","unstructured":"Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122(1):26\u201331","journal-title":"J Pediatr"},{"issue":"9","key":"3559_CR34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0961203308089693","volume":"17","author":"C Langford","year":"2008","unstructured":"Langford C, Sneller M, Hallahan C, Hoffman G, Kammerer W, Talar-Williams C, Fauci AS, Lebovics RS (2008) Clinical features and therapeutic management of subglottic stenosis in patients with Wegener\u2019s granulomatosis. Lupus 17(9):832\u2013836","journal-title":"Lupus"},{"key":"3559_CR35","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00467-012-2198-5","volume":"27","author":"E Siomou","year":"2012","unstructured":"Siomou E, Tramma D, Bowen C, Milford DV (2012) ANCA-associated glomerulonephritis\/systemic vasculitis in childhood: clinical features\u2013outcome. Pediatr Nephrol 27:1911\u20131920","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3559_CR36","first-page":"CS135","volume":"15","author":"B Chipczy\u0144ska","year":"2009","unstructured":"Chipczy\u0144ska B, Gra\u0142ek M, Hautz W, Zegad\u0142o-Mylik M, Kocy\u0142a-Karczmarewicz B, Kanigowska K, Seroczy\u0144ska M, Kepa B, Klimczak-Slaczka D (2009) Orbital tumor as an initial manifestation of Wegener\u2019s granulomatosis in children: a series of four cases. Med Sci Monit 15(8):CS135\u2013138","journal-title":"Med Sci Monit"},{"issue":"3","key":"3559_CR37","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette JC (2003) Rapidly progressive crescentic glomerulonephritis. Kidney Int 63(3):1164\u20131177","journal-title":"Kidney Int"},{"key":"3559_CR38","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1681\/ASN.V1271493","volume":"12","author":"M Hattori","year":"2001","unstructured":"Hattori M, Kurayama H, Koitabashi Y (2001) Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 12:1493\u2013500","journal-title":"J Am Soc Nephrol"},{"key":"3559_CR39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3899\/jrheum.120808","volume":"40","author":"S Gendelman","year":"2013","unstructured":"Gendelman S, Zeft A, Spalding SJ (2013) Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss Syndrome): A contemporary single-center cohort. J Rheumatol 40:929\u2013935","journal-title":"J Rheumatol"},{"key":"3559_CR40","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1046\/j.1523-1755.2002.00605.x","volume":"62","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, No\u00ebl LH, Waldherr R, No\u00ebl LH, Waldherr R, Jayne D, Rasmussen N, Bruijn JA, Hagen, EC Clinical nephrology-epidemiology-clinical trials (2002) Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732\u20131742","journal-title":"Kidney Int"},{"issue":"1","key":"3559_CR41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfh563","volume":"20","author":"I Neumann","year":"2005","unstructured":"Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20(1):96\u2013104","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"3559_CR42","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, No\u00ebl LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21(10):1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"3559_CR43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadonien\u00e9 J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study Group (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"3559_CR44","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DRW Jayne","year":"2007","unstructured":"Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3559_CR45","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.01210214","volume":"9","author":"DG Noone","year":"2014","unstructured":"Noone DG, Twilt M, Hayes WN, Thorner PS, Benseler S, Laxer RM, Parekh RS, Hebert D (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9(10):1684\u20131691","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3559_CR46","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1529-0131(199911)42:11<2365::AID-ANR15>3.0.CO;2-M","volume":"42","author":"QE Whiting-O\u2019Keefe","year":"1999","unstructured":"Whiting-O\u2019Keefe QE, Stone JH, Hellmann DB (1999) Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 42(11):2365\u20132371","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3559_CR47","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87(11):671\u2013678","journal-title":"QJM"},{"issue":"10","key":"3559_CR48","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","volume":"72","author":"P Dolezalova","year":"2013","unstructured":"Dolezalova P, Price-Kuehne FE, \u00d6zen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O\u2019Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, B\u00f6hm M, Krol P, Luqmani RA, Brogan PA (2013) Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis 72(10):1628\u20131633","journal-title":"Ann Rheum Dis"},{"key":"3559_CR49","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidas in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. New Engl J Med 318:1651\u20131657","journal-title":"New Engl J Med"},{"issue":"1","key":"3559_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1546-0096-11-5","volume":"11","author":"NM Wulffraat","year":"2013","unstructured":"Wulffraat NM, Vastert B (2013) Time to share. Pediatr Rheumatol Online J 11(1):5","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"3559_CR51","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3899\/jrheum.120299","volume":"39","author":"K Morishita","year":"2012","unstructured":"Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O\u2019Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA, ARChiVe Investigators Network (2012) Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions. J Rheumatol 39(10):2012\u20132020","journal-title":"J Rheumatol"},{"issue":"6","key":"3559_CR52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jama.298.6.655","volume":"298","author":"X Bosch","year":"2007","unstructured":"Bosch X, Guilabert A, Espinosa V, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody-associated vasculitis. J Am Med Assoc 298(6):655\u2013669","journal-title":"J Am Med Assoc"},{"issue":"4","key":"3559_CR53","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh M, Catapano F, Szpirt W, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57(4):566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"3559_CR54","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (2015) Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 116(6):488\u2013498"},{"issue":"10","key":"3559_CR55","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"K Groot de","year":"2001","unstructured":"de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16(10):2018\u20132027","journal-title":"Nephrol Dial Transplant"},{"key":"3559_CR56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot De","year":"2009","unstructured":"De Groot K, Harper L, Jayne DRW, Suarez LFF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, EUVAS (European Vasculitis Study Group) (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized trial. Ann Intern Med 150:670\u2013680","journal-title":"Ann Intern Med"},{"issue":"4","key":"3559_CR57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"T Wegener","year":"2005","unstructured":"Wegener T, Trial GE (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352(4):351\u2013361","journal-title":"N Engl J Med"},{"key":"3559_CR58","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0197-2456(02)00209-X","volume":"23","author":"The WGET Research Group","year":"2002","unstructured":"The WGET Research Group (2002) Design of the Wegener\u2019s Granulomatosis Etanercept Trial (WGET). Control Clin Trials 23:450\u2013468","journal-title":"Control Clin Trials"},{"issue":"3","key":"3559_CR59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","volume":"15","author":"A Booth","year":"2004","unstructured":"Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D (2004) Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15(3):717\u2013721","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3559_CR60","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/ndt\/gfq187","volume":"25","author":"S Laurino","year":"2010","unstructured":"Laurino S, Chaudhry A, Booth A, Conte G, Jayne D (2010) Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement. Nephrol Dial Transplant 25(10):3307\u20133314","journal-title":"Nephrol Dial Transplant"},{"key":"3559_CR61","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.lpm.2013.02.067","volume":"42","author":"R Jones","year":"2013","unstructured":"Jones R, Harper L, Ballarin J, Blockmans D, Brogan P, Bruchfeld A, Cid M, Dahlsveen K, Dezoysa J, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Jayne D (2013) A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: \u201cMYCYC\u201d. On behalf of the European Vasculitis Study Group. Presse Med 42:678\u2013679","journal-title":"Presse Med"},{"key":"3559_CR62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"M Walsh","year":"2013","unstructured":"Walsh M, Casian A, Flossmann O, Westman K, H\u00f6glund P, Pusey C, Jayne DR, European Vasculitis Study Group (EUVAS) (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402","journal-title":"Kidney Int"},{"key":"3559_CR63","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"3559_CR64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","volume":"14","author":"M Walsh","year":"2013","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D, PEXIVAS Investigators (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials 14:73","journal-title":"Trials"},{"issue":"21","key":"3559_CR65","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"TF Hiemstra","year":"2011","unstructured":"Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, Hauser T, Neumann I, Tesar V, Wissing KM, Pagnoux C, Schmitt W, Jayne DR, European Vasculitis Study Group (EUVAS) (2011) Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis. JAMA 304(21):2381\u20132388","journal-title":"JAMA"},{"key":"3559_CR66","first-page":"1087","volume":"46","author":"JSF Sanders","year":"2007","unstructured":"Sanders JSF, Stassen PM, Kallenberg CGM, Stegeman CA (2007) Azathioprine as compared to cyclophosphamide maintenance therapy for PR3-ANCA-associated vasculitis is associated with increased longterm relapse risk. Clin Exp Rheumatol 46:1087\u20131091","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"3559_CR67","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kem029","volume":"46","author":"C Metzler","year":"2007","unstructured":"Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E, German Network of Rheumatic Diseases (2007) Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener\u2019s granulomatosis. Rheumatology 46(7):1087\u20131091","journal-title":"Rheumatology"},{"issue":"3","key":"3559_CR68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR, European Vasculitis Study Group (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211\u2013220","journal-title":"N Engl J Med"},{"issue":"3","key":"3559_CR69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"J Stone","year":"2010","unstructured":"Stone J, Merkel P, Spiera R, Seo P, Langford C, Hoffman G, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221\u2013232","journal-title":"N Engl J Med"},{"key":"3559_CR70","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Qu\u00e9meneur T, Blanchard-Delaunay C, Godmer P, Pu\u00e9chal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, French Vasculitis Study Group (2014) Rituximab versus azathioprine for maintainance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"3559_CR71","doi-asserted-by":"crossref","unstructured":"Jones RB, Furuta S, Cohen Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K0, Jayne DR; European Vasculitis Society (EUVAS) (2015) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis 74:1178\u201382.","DOI":"10.1136\/annrheumdis-2014-206404"},{"key":"3559_CR72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, RAVE-ITN Research Group (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369:417\u2013427","journal-title":"N Engl J Med"},{"issue":"11","key":"3559_CR73","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.34583","volume":"64","author":"RM Smith","year":"2012","unstructured":"Smith RM, Jones RB, Guerry M-J, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR (2012) Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64(11):3760\u20133769","journal-title":"Arthritis Rheum"},{"issue":"1 Suppl 64","key":"3559_CR74","first-page":"S63","volume":"29","author":"M Menthon de","year":"2011","unstructured":"de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Detree F, Gayraud M, Khellaf M, Penalba C, Legallicier B, Mouthon L, Guillevin L (2011) Infliximab or rituximab for refractory Wegener\u2019s granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients. Clin Exp Rheumatol 29[1 Suppl 64]:S63\u201371","journal-title":"Clin Exp Rheumatol"},{"key":"3559_CR75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/kep148","volume":"48","author":"D Eleftheriou","year":"2009","unstructured":"Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, Dolezalova P, Ozen S, Pilkington C, Woo P, Klein N, Dillon MJ, Brogan PA (2009) Biologic therapy in primary systemic vasculitis of the young. Rheumatology 48:978\u2013986","journal-title":"Rheumatology"},{"key":"3559_CR76","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/rheumatology\/ker150","volume":"51","author":"MJCJ Guerry","year":"2012","unstructured":"Guerry MJCJ, Brogan P, Bruce IN, D\u2019Cruz DP, Harper L, Luqmani R, Pusey CD, Salama AD, Scott DG, Savage CO, Watts RA, Jayne DR (2012) Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology 51:634\u2013643","journal-title":"Rheumatology"},{"issue":"43","key":"3559_CR77","first-page":"2","volume":"2","author":"L Mcgeoch","year":"2015","unstructured":"Mcgeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler S, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand C, Fifi-Mah A, Goulet M, Khalidi N, Khraishi MM, Liang P, Milman N, Pineau CA, Reich H, Samadi N, Shojania K, Taylor-Gjevre R, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux C, Canadian Vasculitis research network (CanVasc) (2015) CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides\u2014executive summary. Can J Kidney Heal Dis 2(43):2\u20136","journal-title":"Can J Kidney Heal Dis"},{"issue":"7","key":"3559_CR78","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DR Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D, Misbah S, O\u2019Donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93(7):433\u2013439","journal-title":"QJM"},{"issue":"9","key":"3559_CR79","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/art.23732","volume":"58","author":"MC Genovese","year":"2008","unstructured":"Genovese MC, Kaine JL, Lowenstein MB, Del GJ, Baldassare A, Schechtman J, Fudman E, Kohen M, Gujrathi S, Trapp RG, Sweiss NJ, Spaniolo G, Dummer W, ACTION Study Group (2008) Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I\/II randomized, blinded, placebo-controlled, dose-ranging study. Arthritis Rheum 58(9):2652\u20132661","journal-title":"Arthritis Rheum"},{"key":"3559_CR80","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","volume":"56","author":"PH Nachman","year":"1999","unstructured":"Nachman PH, Segelmark M, Westman K, Hogan SL, Satterly KK, Jennette JC, Falk R (1999) Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int 56:1544\u20131550","journal-title":"Kidney Int"},{"issue":"12","key":"3559_CR81","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","volume":"91","author":"D Geetha","year":"2011","unstructured":"Geetha D, Alfonso E, True K, Valentina Irazabal M, Specks U, Seo P, Nachman P, Fervenza FC (2011) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicentre experience. Transplantation 91(12):1370\u20131375","journal-title":"Transplantation"},{"key":"3559_CR82","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ndt\/gfg087","volume":"18","author":"A Elmedhem","year":"2003","unstructured":"Elmedhem A, Adu D, Savage COS (2003) Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 18:1001\u20131004","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3559-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:27:17Z","timestamp":1658356037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3559-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3559"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3559-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}